Raiffeisen Bank International AG trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 18.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,000 shares of the company’s stock after selling 20,000 shares during the quarter. Raiffeisen Bank International AG owned about 0.10% of Acadia Healthcare worth $2,492,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter. Wells Fargo & Company MN boosted its position in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the last quarter. Allworth Financial LP purchased a new position in shares of Acadia Healthcare in the second quarter valued at $45,000. Global Retirement Partners LLC bought a new stake in Acadia Healthcare in the second quarter worth $68,000. Finally, Caitong International Asset Management Co. Ltd increased its position in Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the last quarter.
Analysts Set New Price Targets
A number of brokerages have commented on ACHC. TD Cowen lifted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Barclays lifted their price target on Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Finally, KeyCorp raised their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $29.85.
Acadia Healthcare Stock Performance
Acadia Healthcare stock opened at $28.13 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The company has a market capitalization of $2.62 billion, a PE ratio of -2.26, a P/E/G ratio of 9.14 and a beta of 0.62. The company has a 50 day moving average price of $30.70 and a 200-day moving average price of $26.51. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.Acadia Healthcare’s revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
